SCHEMBL31558589

SCHEMBL31558589

CC(C)(C)OC(=O)NCc1[nH]c2ccncc2c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.43
▸ LATS1 O95835 5/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ CACNA1B Q00975 1/20 0.40
▸ CACNA1C Q13936 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ LATS2 Q9NRM7 1/20 0.39
▸ BCHE P06276 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRA4 P48169 1/20 0.36
▸ GABRA6 Q16445 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23478372 1.00 NAMPT (0.43) NAMPTLATS1L3MBTL1CACNA1HCACNA1B
SCHEMBL30765895 0.86 NAMPT (0.43) NAMPTLATS1L3MBTL1CACNA1HCACNA1B
SCHEMBL31558539 0.86 NAMPT (0.43) NAMPTLATS1L3MBTL1CACNA1HCACNA1B
SCHEMBL23452429 0.81 ACHE (0.40) NAMPTHTR6
SCHEMBL30759308 0.74 CACNA1H (0.51) NAMPTLATS1L3MBTL1CACNA1HCACNA1B
SCHEMBL30632885 0.74 SMN1; SMN2 (0.48) NAMPTLATS1CACNA1HCACNA1BCACNA1C
SCHEMBL23478663 0.74 SMN1; SMN2 (0.48) NAMPTLATS1CACNA1HCACNA1BCACNA1C
SCHEMBL30765618 0.72 NAMPT (0.41) NAMPTLATS1L3MBTL1CYP3A4LATS2
SCHEMBL38662207 0.71 CACNA1H (0.54) NAMPTLATS1CACNA1HCACNA1BCACNA1C
SCHEMBL19964841 0.71 SMN1; SMN2 (0.45) NAMPTLATS1CACNA1HCACNA1BCACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119768164-A Pharmaceutical compounds for treating complement-mediated disorders 阿雷克森制药公司 2025-04-04 — — CN disclosed
Send feedback